/ CompletedNot Applicable Evaluation of the Effect of the AI500™ SINGLE-DOSE GEL Medical Device in Patients With Reduced Knee Function: a Post-market Confirmatory Interventional, Single Arm Clinical Investigation
Evaluation of the effect of the AI500™ SINGLE-DOSE GEL medical device in patients with reduced knee function
/ CompletedNot Applicable Evaluation of the Effect on Functionality of the "ST500 SINGLE- DOSE GEL" Medical Device in Patients With Symptomatic Long Head of the Biceps Tendon Injury: a Postmarket Interventional, Single Arm Clinical Investigation
Single arm, post-market, confirmatory, interventional clinical investigation - Medical Device
/ CompletedNot Applicable Assessment of the "PAIN LOTION" Topical Preparation for the Relief of Stiffness, Reduced Mobility, and/or Mild to Moderate Musculoskeletal or Myofascial Pain: a Prospective Pre-market, Interventional, Single Arm Investigation
The application of a novel topical formulation for the treatment of muscular pain and stiffness (Egyfil), containing hyaluronic acid, SH-Polypeptide-6 and SH-Oligopeptide-1, is investigated to evaluate efficacy and safety in 26 patients with stiffness and pain. Single-Arm, Pre-Market, interventional study.
100 Clinical Results associated with Contrad Swiss SA
0 Patents (Medical) associated with Contrad Swiss SA
100 Deals associated with Contrad Swiss SA
100 Translational Medicine associated with Contrad Swiss SA